InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（3 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Broshy Eran, Director. Director active across 2 companies, notably Theravance Biopharma, Inc.. Aggregated, 12 reports have been published. Split: 1 buy · 3 sells. Total volume traded: €965k. History available since 26 April 2022. The latest transaction was filed on 14 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Broshy Eran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
15,757 股0Common StockSEC:0001256230-26-000002:0
14,000 股@ US$20.000.029% mcap50.0% 占其流量Ordinary SharesSEC:0001256230-25-000009:0
15,500 股@ US$18.5025.8% 占其流量Ordinary SharesSEC:0001256230-25-000007:0
29,500 股@ US$18.5049.1% 占其流量Ordinary SharesSEC:0001256230-25-000006:0
11,928 股0Common StockSEC:0001415889-25-014182:0
10,649 股0Ordinary SharesSEC:0001415889-25-014000:0
8,663 股0Common StockSEC:0001415889-24-014248:0
10,537 股0Ordinary SharesSEC:0001415889-24-012908:0
193 股@ US$16.10100.0% 占其流量Common StockSEC:0001415889-23-012566:0
标准退出：2023年11月19日 (T+90)
9,360 股0Common StockSEC:0001415889-23-008754:0
9,132 股0Ordinary SharesSEC:0001415889-23-007374:0
9,852 股0Ordinary SharesSEC:0001415889-22-004328:0
12 条申报中的 12 条
About Broshy Eran
Eran Broshy is a Board Member at Theravance Biopharma, Inc. and Certara, Inc. He brings a strategic perspective to the board, contributing to the direction and governance of the companies. His diverse experience enriches discussions and decisions within the board.
